{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:13:38Z","timestamp":1768587218028,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2030459"],"award-info":[{"award-number":["IIS-2030459"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2033384"],"award-info":[{"award-number":["IIS-2033384"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2030459"],"award-info":[{"award-number":["IIS-2030459"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2033384"],"award-info":[{"award-number":["IIS-2033384"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2030459"],"award-info":[{"award-number":["IIS-2030459"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-2033384"],"award-info":[{"award-number":["IIS-2033384"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harvard Data Science Initiative, Amazon Research Award, and Bayer Early Excellence in Science Award."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Comput Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adverse patient safety events, unintended injuries resulting from medical therapy, were associated with 110,000 deaths in the United States in 2019. A nationwide pandemic (such as COVID-19) further challenges the ability of healthcare systems to ensure safe medication use and the pandemic\u2019s effects on safety events remain poorly understood. Here, we investigate drug safety events across demographic groups before and during a pandemic using a dataset of 1,425,371 reports involving 2,821 drugs and 7,761 adverse events. Among 64 adverse events identified by our analyses, we find 54 increased in frequency during the pandemic, despite a 4.4% decrease in the total number of reports. Out of 53 adverse events with a pre-pandemic gender gap, 33 have seen their gap increase with the pandemic onset. We find that the number of adverse events with an increased reporting ratio is higher in adults (by 16.8%) than in older patients. Our findings have implications for safe medication use and preventable healthcare inequality in public health emergencies.<\/jats:p>","DOI":"10.1038\/s43588-021-00138-4","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T15:41:58Z","timestamp":1633448518000},"page":"666-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Population-scale identification of differential adverse events before and during a pandemic"],"prefix":"10.1038","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5097-2113","authenticated-orcid":false,"given":"Xiang","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Marissa","family":"Sumathipala","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-7228","authenticated-orcid":false,"given":"Marinka","family":"Zitnik","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"138_CR1","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.patter.2020.100108","volume":"1","author":"P Chandak","year":"2020","unstructured":"Chandak, P. & Tatonetti, N. P. Using machine learning to identify adverse drug effects posing increased risk to women. Patterns 1, 100108 (2020).","journal-title":"Patterns"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1038\/s41467-020-18305-y","volume":"11","author":"D Galeano","year":"2020","unstructured":"Galeano, D., Li, S., Gerstein, M. & Paccanaro, A. Predicting the frequencies of drug side effects. Nat. Commun. 11, 4575 (2020).","journal-title":"Nat. Commun."},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.eclinm.2019.10.001","volume":"17","author":"S Watson","year":"2019","unstructured":"Watson, S., Caster, O., Rochon, P. A. & den Ruijter, H. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine 17, 100188 (2019).","journal-title":"EClinicalMedicine"},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong, T. A., Valeyrie-Allanore, L., Wolkenstein, P. & Chosidow, O. Severe cutaneous adverse reactions to drugs. Lancet 390, 1996\u20132011 (2017).","journal-title":"Lancet"},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"102837","DOI":"10.1016\/j.ebiom.2020.102837","volume":"57","author":"R Ietswaart","year":"2020","unstructured":"Ietswaart, R. et al. Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology. EBioMedicine 57, 102837 (2020).","journal-title":"EBioMedicine"},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2213-2600(20)30047-3","volume":"8","author":"Z Lan","year":"2020","unstructured":"Lan, Z. et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Resp. Med. 8, 383\u2013394 (2020).","journal-title":"Lancet Resp. Med."},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0140-6736(19)32491-2","volume":"395","author":"MR Perkin","year":"2020","unstructured":"Perkin, M. R. Perception of severity of adverse events in oral immunotherapy. Lancet 395, 415 (2020).","journal-title":"Lancet"},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","volume":"590","author":"M O\u2019Driscoll","year":"2020","unstructured":"O\u2019Driscoll, M. et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 590, 140\u2013145 (2020).","journal-title":"Nature"},{"key":"138_CR9","doi-asserted-by":"publisher","first-page":"e2017267","DOI":"10.1001\/jamanetworkopen.2020.17267","volume":"3","author":"HW Kaufman","year":"2020","unstructured":"Kaufman, H. W., Chen, Z., Niles, J. & Fesko, Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw. Open 3, e2017267 (2020).","journal-title":"JAMA Netw. Open"},{"key":"138_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-2923-3","volume":"589","author":"S Chang","year":"2020","unstructured":"Chang, S. et al. Mobility network models of COVID-19 explain inequities and inform reopening. Nature 589, 82\u201387 (2020).","journal-title":"Nature"},{"key":"138_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","volume":"586","author":"L Riva","year":"2020","unstructured":"Riva, L. et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113\u2013119 (2020).","journal-title":"Nature"},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"138_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315\u2013320 (2020).","journal-title":"Nature"},{"key":"138_CR14","doi-asserted-by":"crossref","first-page":"eabd4049","DOI":"10.1126\/sciadv.abd4049","volume":"6","author":"X Wu","year":"2020","unstructured":"Wu, X., Nethery, R., Sabath, M., Braun, D. & Dominici, F. Air pollution and COVID-19 mortality in the united states: strengths and limitations of an ecological regression analysis. Sci. Adv. 6, eabd4049 (2020).","journal-title":"Sci. Adv."},{"key":"138_CR15","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz, D. S., Lovegrove, M. C., Shehab, N. & Richards, C. L. Emergency hospitalizations for adverse drug events in older Americans. N. Engl. J. Med. 365, 2002\u20132012 (2011).","journal-title":"N. Engl. J. Med."},{"key":"138_CR16","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1001\/jama.2018.6741","volume":"319","author":"DM Qato","year":"2018","unstructured":"Qato, D. M., Ozenberger, K. & Olfson, M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the united states. JAMA 319, 2289\u20132298 (2018).","journal-title":"JAMA"},{"key":"138_CR17","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41467-018-04605-x","volume":"9","author":"W Song","year":"2018","unstructured":"Song, W. et al. Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat. Commun. 9, 2237 (2018).","journal-title":"Nat. Commun."},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/s41467-020-18742-9","volume":"11","author":"Y Jing","year":"2020","unstructured":"Jing, Y. et al. Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy. Nat. Commun. 11, 4946 (2020).","journal-title":"Nat. Commun."},{"key":"138_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0140-6736(19)32952-6","volume":"396","author":"A Vgontzas","year":"2020","unstructured":"Vgontzas, A. & Renthal, W. Predicting erenumab adverse events with single-cell genomics. Lancet 396, 95\u201396 (2020).","journal-title":"Lancet"},{"key":"138_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jama.2020.16349","volume":"324","author":"CD Spinner","year":"2020","unstructured":"Spinner, C. D. et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA 324, 1048\u20131057 (2020).","journal-title":"JAMA"},{"key":"138_CR21","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","volume":"382","author":"B Gates","year":"2020","unstructured":"Gates, B. Responding to Covid-19-a once-in-a-century pandemic? N. Engl. J. Med. 382, 1677\u20131679 (2020).","journal-title":"N. Engl. J. Med."},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-020-2404-8","volume":"584","author":"S Hsiang","year":"2020","unstructured":"Hsiang, S. et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature 584, 262\u2013267 (2020).","journal-title":"Nature"},{"key":"138_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP Van Puijenbroek","year":"2002","unstructured":"Van Puijenbroek, E. P. et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol. Drug Safety 11, 3\u201310 (2002).","journal-title":"Pharmacoepidemiol. Drug Safety"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"100258","DOI":"10.1016\/j.ajogmf.2020.100258","volume":"2","author":"V Berghella","year":"2020","unstructured":"Berghella, V., Burd, J., Anderson, K., Boelig, R. & Roman, A. Decreased incidence of preterm birth during COVID-19 pandemic. Am. J. Obstet. Gynecol. MFM 2, 100258 (2020).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1126\/science.abc9520","volume":"369","author":"A Aassve","year":"2020","unstructured":"Aassve, A., Cavalli, N., Mencarini, L., Plach, S. & Bacci, M. L. The COVID-19 pandemic and human fertility. Science 369, 370\u2013371 (2020).","journal-title":"Science"},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77, 683\u2013690 (2020).","journal-title":"JAMA Neurol."},{"key":"138_CR27","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1001\/jama.2020.21753","volume":"324","author":"IV Vahia","year":"2020","unstructured":"Vahia, I. V., Jeste, D. V. & Reynolds, C. F. Older adults and the mental health effects of COVID-19. JAMA 324, 2253\u20132254 (2020).","journal-title":"JAMA"},{"key":"138_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown, E. G., Wood, L. & Wood, S. The medical dictionary for regulatory activities (MedDRA). Drug Safety 20, 109\u2013117 (1999).","journal-title":"Drug Safety"},{"key":"138_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","volume":"31","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi, H. K., Libby, P. & Ridker, P. M. COVID-19\u2014a vascular disease. Trends Cardiovasc. Med. 31, 1\u20135 (2020).","journal-title":"Trends Cardiovasc. Med"},{"key":"138_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1086\/515209","volume":"28","author":"WE Stamm","year":"1999","unstructured":"Stamm, W. E. & Raz, R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin. Infect. Dis. 28, 723\u2013725 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"138_CR31","doi-asserted-by":"publisher","first-page":"e1380","DOI":"10.1016\/S2214-109X(20)30366-1","volume":"8","author":"JD Hamadani","year":"2020","unstructured":"Hamadani, J. D. et al. Immediate impact of stay-at-home orders to control COVID-19 transmission on socioeconomic conditions, food insecurity, mental health, and intimate partner violence in Bangladeshi women and their families: an interrupted time series. Lancet Glob. Health 8, e1380\u2013e1389 (2020).","journal-title":"Lancet Glob. Health"},{"key":"138_CR32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3389\/fpsyt.2020.00700","volume":"11","author":"S Zaami","year":"2020","unstructured":"Zaami, S., Marinelli, E. & Var\u00ec, M. R. New trends of substance abuse during COVID-19 pandemic: an international perspective. Front. Psychiatry 11, 700 (2020).","journal-title":"Front. Psychiatry"},{"key":"138_CR33","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMp2032369","volume":"383","author":"D Rubin","year":"2020","unstructured":"Rubin, D., Chan-Tack, K., Farley, J. & Sherwat, A. FDA approval of remdesivir\u2014a step in the right direction. N. Engl. J. Med. 383, 2598\u20132600 (2020).","journal-title":"N. Engl. J. Med."},{"key":"138_CR34","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","volume":"382","author":"J Grein","year":"2020","unstructured":"Grein, J. et al. Compassionate use of remdesivir for patients with severe COVID-19. N. Engl. J. Med. 382, 2327\u20132336 (2020).","journal-title":"N. Engl. J. Med."},{"key":"138_CR35","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395, 1569\u20131578 (2020).","journal-title":"Lancet"},{"key":"138_CR36","doi-asserted-by":"publisher","first-page":"110532","DOI":"10.1016\/j.biopha.2020.110532","volume":"130","author":"Q Fan","year":"2020","unstructured":"Fan, Q., Zhang, B., Ma, J. & Zhang, S. Safety profile of the antiviral drug remdesivir: an update. Biomed. Pharmacother. 130, 110532 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"138_CR37","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.3390\/ijerph17113926","volume":"17","author":"V Orlando","year":"2020","unstructured":"Orlando, V. et al. Gender differences in medication use: a drug utilization study based on real world data. Int. J. Environ. Res. Public Health 17, 3926 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"138_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajic.2020.11.006","volume":"49","author":"L Wee","year":"2020","unstructured":"Wee, L., Conceicao, E., Sim, J., Aung, M. & Venkatachalam, I. The impact of visitor restrictions on healthcare-associated respiratory viral infections during the COVID-19 pandemic: experience of a tertiary hospital in Singapore. Am. J. Infect. Control 49, 134 (2020).","journal-title":"Am. J. Infect. Control"},{"key":"138_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pcad.2020.04.005","volume":"64","author":"G Hall","year":"2021","unstructured":"Hall, G., Laddu, D. R., Phillips, S. A., Lavie, C. J. & Arena, R. A tale of two pandemics: how will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another?. Progr. Cardiovasc. Dis. 64, 108\u2013110 (2021).","journal-title":"Progr. Cardiovasc. Dis."},{"key":"138_CR40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41562-020-0928-4","volume":"4","author":"WM de Souza","year":"2020","unstructured":"de Souza, W. M. et al. Epidemiological and clinical characteristics of the Covid-19 epidemic in Brazil. Nat. Hum. Behav. 4, 856\u2013865 (2020).","journal-title":"Nat. Hum. Behav."},{"key":"138_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40273-019-00777-6","volume":"37","author":"D Thesmar","year":"2019","unstructured":"Thesmar, D. et al. Combining the power of artificial intelligence with the richness of healthcare claims data: opportunities and challenges. PharmacoEconomics 37, 745\u2013752 (2019).","journal-title":"PharmacoEconomics"},{"key":"138_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41746-021-00383-x","volume":"4","author":"H Estiri","year":"2021","unstructured":"Estiri, H. et al. Predicting Covid-19 mortality with electronic medical records. NPJ Digit. Med. 4, 15 (2021).","journal-title":"NPJ Digit. Med."},{"key":"138_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt.3623","volume":"34","author":"M Sarangdhar","year":"2016","unstructured":"Sarangdhar, M. et al. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data. Nat. Biotechnol. 34, 697\u2013700 (2016).","journal-title":"Nat. Biotechnol."},{"key":"138_CR44","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","volume":"167","author":"TJ Moore","year":"2007","unstructured":"Moore, T. J., Cohen, M. R. & Furberg, C. D. Serious adverse drug events reported to the food and drug administration, 1998\u20132005. Arch. Intern. Med. 167, 1752\u20131759 (2007).","journal-title":"Arch. Intern. Med."},{"key":"138_CR45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S2213-8587(17)30257-7","volume":"5","author":"GP Fadini","year":"2017","unstructured":"Fadini, G. P. & Avogaro, A. SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System. Lancet Diabetes Endocrinol. 5, 680\u2013681 (2017).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"138_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0140-6736(18)31542-3","volume":"392","author":"SG Al-Kindi","year":"2018","unstructured":"Al-Kindi, S. G. & Oliveira, G. H. Reporting of immune checkpoint inhibitor-associated myocarditis. Lancet 392, 382\u2013383 (2018).","journal-title":"Lancet"},{"key":"138_CR47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","volume":"26","author":"ST Liu","year":"2020","unstructured":"Liu, S. T. et al. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat. Med. 26, 1708\u20131713 (2020).","journal-title":"Nat. Med."},{"key":"138_CR48","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/S0140-6736(17)33244-0","volume":"390","author":"S Chen","year":"2017","unstructured":"Chen, S., Wu, H., Yang, T., Li, B. & Sun, H. Early outcomes of perioperative statin therapy for elderly patients undergoing off-pump coronary artery bypass surgery: a propensity score-matched study. Lancet 390, S106 (2017).","journal-title":"Lancet"},{"key":"138_CR49","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S1470-2045(16)30250-9","volume":"17","author":"T-M Yu","year":"2016","unstructured":"Yu, T.-M. et al. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol. 17, 1419\u20131425 (2016).","journal-title":"Lancet Oncol."},{"key":"138_CR50","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 11, 6317 (2020).","journal-title":"Nat. Commun."},{"key":"138_CR51","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1038\/s41467-020-18848-0","volume":"11","author":"A-S Rudberg","year":"2020","unstructured":"Rudberg, A.-S. et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat. Commun. 11, 5064 (2020).","journal-title":"Nat. Commun."},{"key":"138_CR52","doi-asserted-by":"publisher","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti, N. P., Patrick, P. Y., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra31 (2012).","journal-title":"Sci. Transl. Med."},{"key":"138_CR53","doi-asserted-by":"publisher","first-page":"18671","DOI":"10.1038\/s41598-020-74910-3","volume":"10","author":"B Wernly","year":"2020","unstructured":"Wernly, B. et al. Sex-specific outcome disparities in very old patients admitted to intensive care medicine: a propensity matched analysis. Sci. Rep. 10, 18671 (2020).","journal-title":"Sci. Rep."},{"key":"138_CR54","doi-asserted-by":"publisher","first-page":"13601","DOI":"10.1038\/s41598-020-70653-3","volume":"10","author":"G Bonaldo","year":"2020","unstructured":"Bonaldo, G., Noseda, R., Ceschi, A., Vaccheri, A. & Motola, D. Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data. Sci. Rep. 10, 13601 (2020).","journal-title":"Sci. Rep."},{"key":"138_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40264-020-00911-w","volume":"43","author":"O Caster","year":"2020","unstructured":"Caster, O., Aoki, Y., Gattepaille, L. M. & Grundmark, B. Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting false-positive associations. Drug Safety 43, 479\u2013487 (2020).","journal-title":"Drug Safety"},{"key":"138_CR56","unstructured":"Hyndman, R. J. & Athanasopoulos, G. Forecasting: Principles and Practice (OTexts, 2018)."},{"key":"138_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78697-1","volume":"10","author":"I Ayg\u00fcn","year":"2020","unstructured":"Ayg\u00fcn, I., Kaya, M. & Alhajj, R. Identifying side effects of commonly used drugs in the treatment of COVID 19. Sci. Rep. 10, 21508 (2020).","journal-title":"Sci. Rep."},{"key":"138_CR58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41598-020-57799-w","volume":"10","author":"T Geldof","year":"2020","unstructured":"Geldof, T., Popovic, D., Van Damme, N., Huys, I. & Van Dyck, W. Nearest neighbour propensity score matching and bootstrapping for estimating binary patient response in oncology: a Monte Carlo simulation. Sci. Rep. 10, 964 (2020).","journal-title":"Sci. Rep."},{"key":"138_CR59","doi-asserted-by":"publisher","unstructured":"Zhang, X., Sumathipala, M. & Zitnik, M. Population-scale patient safety dataset from 2013 to 2020 (data resource). Harvard Dataverse https:\/\/doi.org\/10.7910\/DVN\/G9SHDA","DOI":"10.7910\/DVN\/G9SHDA"},{"key":"138_CR60","doi-asserted-by":"publisher","unstructured":"Zhang, X., Sumathipala, M. & Zitnik, M. Population-scale identification of differential adverse events before and during a nationwide pandemic (code resource). figshare https:\/\/doi.org\/10.6084\/m9.figshare.15088161.v1","DOI":"10.6084\/m9.figshare.15088161.v1"}],"container-title":["Nature Computational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43588-021-00138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43588-021-00138-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43588-021-00138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T21:31:42Z","timestamp":1670103102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43588-021-00138-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1038\/s43588-021-00138-4","relation":{},"ISSN":["2662-8457"],"issn-type":[{"value":"2662-8457","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}